Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-08-05 5:52 pm Purchase | 13G | ALLOVIR INC ALVR | GILEAD SCIENCES INC. GILD | 13,704,416 14.8% | 13,704,416 (New Position) | View |
| 2022-07-08 4:56 pm Purchase | 13G | GILEAD SCIENCES INC GILD | BlackRock Inc. BLK | 126,932,693 10.1% | 7,971,487 (+6.70%) | View |
| 2022-02-17 2:43 pm Purchase | 13G | HOOKIPA PHARMA INC HOOK | GILEAD SCIENCES INC. GILD | 3,759,465 12.9% | 1,666,666 (+79.64%) | View |
| 2022-02-17 2:11 pm Unchanged | 13G | AGENUS INC AGEN | GILEAD SCIENCES INC. GILD | 11,111,111 4.3% | 0 (Unchanged) | View |
| 2022-02-11 12:22 pm Sale | 13G | GILEAD SCIENCES INC GILD | Capital Research Global Investors | 107,156,981 8.5% | -14,515,418 (-11.93%) | View |
| 2022-02-10 4:55 pm Purchase | 13G | SIERRA ONCOLOGY INC SRRA | GILEAD SCIENCES INC. GILD | 1,450,566 9.2% | 377,266 (+35.15%) | View |
| 2022-02-10 4:51 pm Sale | 13G | ALLOGENE THERAPEUTICS INC ALLO | GILEAD SCIENCES INC. GILD | 1,156,689 0.8% | -6,330,000 (-84.55%) | View |
| 2022-02-10 4:50 pm Unchanged | 13G | AGENUS INC AGEN | GILEAD SCIENCES INC. GILD | 11,111,111 4.3% | 0 (Unchanged) | View |
| 2022-02-10 08:11 am Purchase | 13G | GILEAD SCIENCES INC GILD | VANGUARD GROUP INC | 105,803,799 8.43% | 3,016,782 (+2.93%) | View |
| 2022-02-01 5:14 pm Purchase | 13G | GILEAD SCIENCES INC GILD | BlackRock Inc. BLK | 118,961,206 9.5% | 7,777,872 (+7.00%) | View |
| 2021-09-10 12:17 pm Purchase | 13G | TANGO THERAPEUTICS INC TNGX | GILEAD SCIENCES INC. GILD | 4,854,443 5.5% | 4,854,443 (New Position) | View |
| 2021-02-16 3:46 pm Unchanged | 13G | GILEAD SCIENCES INC GILD | Capital Research Global Investors | 121,672,399 9.7% | 0 (Unchanged) | View |
| 2021-02-16 1:27 pm Purchase | 13G | GILEAD SCIENCES INC GILD | Capital Research Global Investors | 121,672,399 9.7% | 36,539,514 (+42.92%) | View |
| 2021-02-12 4:36 pm Purchase | 13G | HOOKIPA PHARMA INC HOOK | GILEAD SCIENCES INC. GILD | 2,092,799 7.2% | 425,531 (+25.52%) | View |
| 2021-02-10 10:57 am Sale | 13G | GILEAD SCIENCES INC GILD | VANGUARD GROUP INC | 102,787,017 8.2% | -984,831 (-0.95%) | View |
| 2021-02-02 4:51 pm Sale | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC. GILD | 22,723,156 35% | -6,775,268 (-22.97%) | View |
| 2021-01-29 09:56 am Purchase | 13G | GILEAD SCIENCES INC GILD | BlackRock Inc. BLK | 111,183,334 8.9% | 4,709,740 (+4.42%) | View |
| 2020-10-26 4:33 pm Purchase | 13G | JOUNCE THERAPEUTICS INC. JNCE | GILEAD SCIENCES INC. GILD | 5,539,727 13.9% | 5,539,727 (New Position) | View |
| 2020-07-17 2:01 pm Purchase | 13D | ARCUS BIOSCIENCES INC RCUS | GILEAD SCIENCES INC. GILD | 29,498,424 35% | 29,498,424 (New Position) | View |
| 2020-02-14 1:14 pm Unchanged | 13G | HOOKIPA PHARMA INC HOOK | GILEAD SCIENCES INC. GILD | 1,667,268 7.7% | 0 (Unchanged) | View |